SAN GERONIMO, Calif., Jan. 4, 2012 (GLOBE NEWSWIRE) -- Virogen Inc. (OTC:VRNI), a holding company specializing in data security and encryption technology, today cited the specific revenue potential for the company if and when it finalizes the acquisition of a company in the Southeast US that currently operates four data centers. The company's CEO, Paul Hogan, wished to specify to shareholders the revenue potential of this acquisition.
Mr. Hogan commented, "Bringing on these multiple new data centers would add approximately $7 million to our gross revenue and approximately $3 million to our net operating revenue. We are very excited and confident that this acquisition will become finalized during the first quarter of 2012."
Yesterday, the company announced that it is currently involved in the due diligence process regarding the acquisition in order to accommodate anticipated growth and expansion in 2012. The company's business model requires vast cloud computing capabilities as T3 recently announced plans to release a consumer product that will provide data tracking and protection for laptops and home PCs in addition to its enterprise-level solutions.
About Virogen, Inc.
Virogen, Inc. is a technology holding company. The company's wholly owned subsidiary, Tiger Team Technologies "T3," has developed a very unique suite of copyrighted tools to address the network and database security needs of enterprise level companies and corporations. T3's risk management offering provides an unprecedented level of security and liability protection, positioning it as the only company with a comprehensive solution to data security breaches for its clients. T3's primary markets include medical service providers, financial services firms, brokerages and currency transaction platforms, consumer credit card companies, banking entities, retailers, defense and government related operations.
Forward-Looking Statements:
This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Virogen, Inc. and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions the occurrence of unanticipated events or changes to future operating results.